Clinical Assessment of Injectable Composite Versus Packable Composite in Treatment of Carious Primary Anterior Teeth
Launched by CAIRO UNIVERSITY · May 18, 2025
Trial Information
Current as of July 27, 2025
Not yet recruiting
Keywords
ClinConnect Summary
This clinical trial is looking at two different types of materials used to fill cavities in children's front teeth, which are called primary anterior teeth. The researchers want to see how well an injectable composite material works compared to a packable composite material in treating these cavities. The study is still in the planning stage and hasn't started recruiting participants yet.
To be eligible for the trial, children must have cavities in their front teeth that can be restored, and they should have certain types of cavities known as class III, IV, or V. The trial is open to all children, but it excludes those with teeth that are too badly decayed to save or have other specific dental issues. If eligible, participants will receive one of the two types of treatments, and their progress will be monitored to determine how well each material works. This study aims to find the best option for treating cavities in young children's teeth.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Children with caries in primary anterior teeth.
- • Caries involving class III, IV, V or multisurface caries
- • Restorable anterior teeth
- • Pre operative Radiograph showing at least half of the root is not resorbed).
- Exclusion Criteria:
- • Badly decayed non restorable anterior teeth
- • Signs and symptoms of root resorption (more than half the root is resorbed)
- • Presence of bony resorption
- • Presence of pathological root resorption
- • Tooth Mobility
About Cairo University
Cairo University, a premier institution in Egypt, is dedicated to advancing medical research and education through innovative clinical trials. With a strong emphasis on improving healthcare outcomes, the university collaborates with various stakeholders to conduct rigorous scientific studies that address critical health challenges. Leveraging its extensive resources and expert faculty, Cairo University aims to contribute valuable insights to the medical community and enhance patient care both locally and globally. Through its commitment to ethical research practices and excellence, the university plays a pivotal role in shaping the future of healthcare in the region.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Cairo, , Egypt
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported